1. Haffner, M. E. Adopting orphan drugs — two dozen years of treating rare diseases. N. Engl. J. Med. 354, 445–447 (2006).
2. Cheung R. Y., Cohen J. C. & Illingworth P. Orphan drug policies: implications for the United States, Canada and developing countries. Health Law J. 12, 183–200 (2004).
3. EURORDIS. Orphan drugs: rising to the challenge to ensure a better future for 30 million patients in Europe. EURORDIS website [
online
], (2009).
4. EURORDIS. About rare diseases. EURORDIS website [
online
], (2010).
5. La Revue Prescire – Enquête. Médicaments pour les maladies rares: bilan contrasté en Europe — Synthèse élaborée collectivement par la Rédaction. La Revue Prescire 26, 781 (2006) (in French).